Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms

Peter Johansson, Ruben Mesa, Robyn Scherber, Johanna Abelsson, Jan Samuelsson, Gunnar Birgegård, Björn Andréasson

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) is a validated quality of life (QoL) instrument. In our Swedish cohort of 114 patients the symptomatic burden was found to be severe, with fatigue reported in 88% of the patients and reduced QoL in the majority of patients. Patients with primary myelofibrosis had the highest scores, low QoL, for most MPN-SAF items, compared to patients with polycythemia vera and essential thrombocythemia. Higher age showed significant associations with the BFI (Brief Fatigue Inventory) score, early satiety, concentration problems, dizziness, insomnia, cough and weight loss. Blood values, disease duration and myelosuppressive treatment did not significantly associate with any of the MPN-SAF items, with the exception of higher hemoglobin, which correlated with sad mood. Male patients with MPN scored significantly higher as regards sexual problems and weight loss compared to female patients. Overall, the MPN-SAF was found to be a valid instrument for assessing symptomatic burden among this population.

Original languageEnglish (US)
Pages (from-to)441-444
Number of pages4
JournalLeukemia and Lymphoma
Volume53
Issue number3
DOIs
StatePublished - Mar 1 2012
Externally publishedYes

Fingerprint

Quality of Life
Symptom Assessment
Neoplasms
Fatigue
Weight Loss
Essential Thrombocythemia
Polycythemia Vera
Primary Myelofibrosis
Hematologic Diseases
Sleep Initiation and Maintenance Disorders
Dizziness
Cough
Hemoglobins
Equipment and Supplies
Population
Therapeutics

Keywords

  • Myeloproliferative neoplasms
  • Quality of life

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Johansson, P., Mesa, R., Scherber, R., Abelsson, J., Samuelsson, J., Birgegård, G., & Andréasson, B. (2012). Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms. Leukemia and Lymphoma, 53(3), 441-444. https://doi.org/10.3109/10428194.2011.619608

Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms. / Johansson, Peter; Mesa, Ruben; Scherber, Robyn; Abelsson, Johanna; Samuelsson, Jan; Birgegård, Gunnar; Andréasson, Björn.

In: Leukemia and Lymphoma, Vol. 53, No. 3, 01.03.2012, p. 441-444.

Research output: Contribution to journalArticle

Johansson, P, Mesa, R, Scherber, R, Abelsson, J, Samuelsson, J, Birgegård, G & Andréasson, B 2012, 'Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms', Leukemia and Lymphoma, vol. 53, no. 3, pp. 441-444. https://doi.org/10.3109/10428194.2011.619608
Johansson, Peter ; Mesa, Ruben ; Scherber, Robyn ; Abelsson, Johanna ; Samuelsson, Jan ; Birgegård, Gunnar ; Andréasson, Björn. / Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms. In: Leukemia and Lymphoma. 2012 ; Vol. 53, No. 3. pp. 441-444.
@article{4a59a18a53034153a21a9c023b4cd297,
title = "Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms",
abstract = "The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) is a validated quality of life (QoL) instrument. In our Swedish cohort of 114 patients the symptomatic burden was found to be severe, with fatigue reported in 88{\%} of the patients and reduced QoL in the majority of patients. Patients with primary myelofibrosis had the highest scores, low QoL, for most MPN-SAF items, compared to patients with polycythemia vera and essential thrombocythemia. Higher age showed significant associations with the BFI (Brief Fatigue Inventory) score, early satiety, concentration problems, dizziness, insomnia, cough and weight loss. Blood values, disease duration and myelosuppressive treatment did not significantly associate with any of the MPN-SAF items, with the exception of higher hemoglobin, which correlated with sad mood. Male patients with MPN scored significantly higher as regards sexual problems and weight loss compared to female patients. Overall, the MPN-SAF was found to be a valid instrument for assessing symptomatic burden among this population.",
keywords = "Myeloproliferative neoplasms, Quality of life",
author = "Peter Johansson and Ruben Mesa and Robyn Scherber and Johanna Abelsson and Jan Samuelsson and Gunnar Birgeg{\aa}rd and Bj{\"o}rn Andr{\'e}asson",
year = "2012",
month = "3",
day = "1",
doi = "10.3109/10428194.2011.619608",
language = "English (US)",
volume = "53",
pages = "441--444",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms

AU - Johansson, Peter

AU - Mesa, Ruben

AU - Scherber, Robyn

AU - Abelsson, Johanna

AU - Samuelsson, Jan

AU - Birgegård, Gunnar

AU - Andréasson, Björn

PY - 2012/3/1

Y1 - 2012/3/1

N2 - The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) is a validated quality of life (QoL) instrument. In our Swedish cohort of 114 patients the symptomatic burden was found to be severe, with fatigue reported in 88% of the patients and reduced QoL in the majority of patients. Patients with primary myelofibrosis had the highest scores, low QoL, for most MPN-SAF items, compared to patients with polycythemia vera and essential thrombocythemia. Higher age showed significant associations with the BFI (Brief Fatigue Inventory) score, early satiety, concentration problems, dizziness, insomnia, cough and weight loss. Blood values, disease duration and myelosuppressive treatment did not significantly associate with any of the MPN-SAF items, with the exception of higher hemoglobin, which correlated with sad mood. Male patients with MPN scored significantly higher as regards sexual problems and weight loss compared to female patients. Overall, the MPN-SAF was found to be a valid instrument for assessing symptomatic burden among this population.

AB - The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF) is a validated quality of life (QoL) instrument. In our Swedish cohort of 114 patients the symptomatic burden was found to be severe, with fatigue reported in 88% of the patients and reduced QoL in the majority of patients. Patients with primary myelofibrosis had the highest scores, low QoL, for most MPN-SAF items, compared to patients with polycythemia vera and essential thrombocythemia. Higher age showed significant associations with the BFI (Brief Fatigue Inventory) score, early satiety, concentration problems, dizziness, insomnia, cough and weight loss. Blood values, disease duration and myelosuppressive treatment did not significantly associate with any of the MPN-SAF items, with the exception of higher hemoglobin, which correlated with sad mood. Male patients with MPN scored significantly higher as regards sexual problems and weight loss compared to female patients. Overall, the MPN-SAF was found to be a valid instrument for assessing symptomatic burden among this population.

KW - Myeloproliferative neoplasms

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84857512891&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857512891&partnerID=8YFLogxK

U2 - 10.3109/10428194.2011.619608

DO - 10.3109/10428194.2011.619608

M3 - Article

VL - 53

SP - 441

EP - 444

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -